Shockwave Medical, Inc.

NasdaqGS:SWAV Stock Report

Market Cap: US$10.7b

Shockwave Medical Management

Management criteria checks 4/4

Shockwave Medical's CEO is Doug Godshall, appointed in May 2017, has a tenure of 6.83 years. total yearly compensation is $8.42M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $27.00M. The average tenure of the management team and the board of directors is 3.5 years and 5.2 years respectively.

Key information

Doug Godshall

Chief executive officer

US$8.4m

Total compensation

CEO salary percentage7.7%
CEO tenure6.8yrs
CEO ownership0.3%
Management average tenure3.5yrs
Board average tenure5.2yrs

Recent management updates

Recent updates

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18
Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06
There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24
Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09
Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Dec 27
Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Dec 13
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Nov 17
What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Oct 19
Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Oct 06
Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Sep 20
Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Sep 07
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

Jul 10
When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

Jun 26
We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Jun 13
We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

May 29
Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

The Trend Of High Returns At Shockwave Medical (NASDAQ:SWAV) Has Us Very Interested

Mar 27
The Trend Of High Returns At Shockwave Medical (NASDAQ:SWAV) Has Us Very Interested

Shockwave Medical's (NASDAQ:SWAV) Earnings Aren't As Good As They Appear

Mar 06
Shockwave Medical's (NASDAQ:SWAV) Earnings Aren't As Good As They Appear

Should You Think About Buying ShockWave Medical, Inc. (NASDAQ:SWAV) Now?

Feb 28
Should You Think About Buying ShockWave Medical, Inc. (NASDAQ:SWAV) Now?

Is ShockWave Medical, Inc. (NASDAQ:SWAV) Trading At A 29% Discount?

Feb 07
Is ShockWave Medical, Inc. (NASDAQ:SWAV) Trading At A 29% Discount?

CEO Compensation Analysis

How has Doug Godshall's remuneration changed compared to Shockwave Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$147m

Sep 30 2023n/an/a

US$244m

Jun 30 2023n/an/a

US$244m

Mar 31 2023n/an/a

US$241m

Dec 31 2022US$8mUS$644k

US$216m

Sep 30 2022n/an/a

US$88m

Jun 30 2022n/an/a

US$55m

Mar 31 2022n/an/a

US$29m

Dec 31 2021US$7mUS$575k

-US$9m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$53m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$5mUS$546k

-US$66m

Sep 30 2020n/an/a

-US$65m

Jun 30 2020n/an/a

-US$65m

Mar 31 2020n/an/a

-US$57m

Dec 31 2019US$2mUS$477k

-US$51m

Sep 30 2019n/an/a

-US$48m

Jun 30 2019n/an/a

-US$45m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$511kUS$376k

-US$41m

Compensation vs Market: Doug's total compensation ($USD8.42M) is below average for companies of similar size in the US market ($USD12.26M).

Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.


CEO

Doug Godshall (58 yo)

6.8yrs

Tenure

US$8,418,871

Compensation

Mr. Douglas E. Godshall, also known as Doug, M.B.A., is Director of Saluda Medical, Inc. He serves as Chair of the Board of Galvanize Therapeutics, Inc. since September 2022. He has been the Chief Executiv...


Leadership Team

NamePositionTenureCompensationOwnership
Douglas Godshall
President6.8yrsUS$8.42m0.25%
$ 27.0m
Isaac Zacharias
Chief Commercial Officer5.3yrsUS$7.03m0.16%
$ 17.5m
Daniel Hawkins
Founder and Senior Advisor15.2yrsno datano data
John Adams
Co-Founder and Technical Advisor15.2yrsno datano data
Renee Gaeta
Chief Financial Officerless than a yearno data0.053%
$ 5.7m
Luis Morales
Senior Vice President of Global Operationsless than a yearno datano data
Trinh Phung
Chief Accounting Officer2.1yrsno data0.083%
$ 8.9m
Debbie Kaster
Vice President of Investor Relationsless than a yearno datano data
Hajime Tada
General Counsel & Secretary4.8yrsno datano data
Robert Fletcher
Senior Vice President of Marketing & Market Access7.7yrsno datano data
Dave Cox
Vice President of Salesless than a yearno datano data
Cathy Harnett
Senior Director of Human Resources2.2yrsno datano data

3.5yrs

Average Tenure

52yo

Average Age

Experienced Management: SWAV's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Douglas Godshall
President6.8yrsUS$8.42m0.25%
$ 27.0m
Antoine Papiernik
Independent Director10.7yrsUS$237.40kno data
Frederic Moll
Independent Director12.8yrsUS$234.90k0.77%
$ 82.4m
Charles Larkin
Independent Chairman of the Board5.2yrsUS$297.40k0.0095%
$ 1.0m
Laura Francis
Independent Director5.2yrsUS$257.40k0.011%
$ 1.2m
Sara Toyloy
Independent Director3yrsUS$239.90k0.0079%
$ 849.7k
Maria Sainz
Independent Director3.7yrsUS$249.90k0.0060%
$ 639.1k
Kevin Ballinger
Directorless than a yearno datano data
F. Watkins
Independent Director10.8yrsUS$239.90k0.010%
$ 1.1m

5.2yrs

Average Tenure

57yo

Average Age

Experienced Board: SWAV's board of directors are considered experienced (5.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.